Timothy S. Cabral, a director at Doximity, Inc., has filed a notice to sell 10,721 shares of the company's common stock. This filing, made on November 5, 2026, is significant as it follows a stock option exercise, indicating a potential shift in Cabral's investment strategy.

Doximity, Inc. is a prominent player in the field of computer programming services, according to its SEC filings. The company, which trades on the NYSE under the ticker symbol DOCS, has been actively involved in the healthcare technology sector, providing services that connect healthcare professionals.

The recent SEC filing shows that Cabral acquired 7,500 shares through a stock option exercise on the same day he filed to sell. Additionally, he previously acquired 3,221 shares as restricted stock on August 27, 2026. The aggregate market value of the shares he plans to sell is approximately $375,235.

This move may affect various stakeholders, including investors and other directors at Doximity, as changes in executive holdings can influence market perception and investor confidence. The filing does not specify any upcoming events or votes related to this transaction.

As Doximity continues to operate in a competitive landscape, the implications of such transactions could resonate throughout the computer programming services sector.